Global Drug Reprofiling Market Growth (Status and Outlook) 2022-2028
- LP 4861032
- 89 Pages
- February 2022
- Medical Devices
The United States Drug Reprofiling market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug Reprofiling market, reaching US$ million by the year 2028. As for the Europe Drug Reprofiling landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug Reprofiling players cover Novartis AG, Abbott Healthcare, Pfizer, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Reprofiling market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Orally
Intravenously
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Central Nervous Disorders
Cardiovascular Disorders
Oncology
others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis AG
Abbott Healthcare
Pfizer
Johnson & Johnson
Hoffmann-La Roche
Sandoz
Mylan Inc.
Teva Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Reprofiling Market Size 2017-2028
2.1.2 Drug Reprofiling Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug Reprofiling Segment by Type
2.2.1 Orally
2.2.2 Intravenously
2.3 Drug Reprofiling Market Size by Type
2.3.1 Drug Reprofiling Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug Reprofiling Market Size Market Share by Type (2017-2022)
2.4 Drug Reprofiling Segment by Application
2.4.1 Central Nervous Disorders
2.4.2 Cardiovascular Disorders
2.4.3 Oncology
2.4.4 others
2.5 Drug Reprofiling Market Size by Application
2.5.1 Drug Reprofiling Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug Reprofiling Market Size Market Share by Application (2017-2022)
3 Drug Reprofiling Market Size by Player
3.1 Drug Reprofiling Market Size Market Share by Players
3.1.1 Global Drug Reprofiling Revenue by Players (2020-2022)
3.1.2 Global Drug Reprofiling Revenue Market Share by Players (2020-2022)
3.2 Global Drug Reprofiling Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Reprofiling by Regions
4.1 Drug Reprofiling Market Size by Regions (2017-2022)
4.2 Americas Drug Reprofiling Market Size Growth (2017-2022)
4.3 APAC Drug Reprofiling Market Size Growth (2017-2022)
4.4 Europe Drug Reprofiling Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug Reprofiling Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drug Reprofiling Market Size by Country (2017-2022)
5.2 Americas Drug Reprofiling Market Size by Type (2017-2022)
5.3 Americas Drug Reprofiling Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Reprofiling Market Size by Region (2017-2022)
6.2 APAC Drug Reprofiling Market Size by Type (2017-2022)
6.3 APAC Drug Reprofiling Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Reprofiling by Country (2017-2022)
7.2 Europe Drug Reprofiling Market Size by Type (2017-2022)
7.3 Europe Drug Reprofiling Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Reprofiling by Region (2017-2022)
8.2 Middle East & Africa Drug Reprofiling Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug Reprofiling Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Reprofiling Market Forecast
10.1 Global Drug Reprofiling Forecast by Regions (2023-2028)
10.1.1 Global Drug Reprofiling Forecast by Regions (2023-2028)
10.1.2 Americas Drug Reprofiling Forecast
10.1.3 APAC Drug Reprofiling Forecast
10.1.4 Europe Drug Reprofiling Forecast
10.1.5 Middle East & Africa Drug Reprofiling Forecast
10.2 Americas Drug Reprofiling Forecast by Country (2023-2028)
10.2.1 United States Drug Reprofiling Market Forecast
10.2.2 Canada Drug Reprofiling Market Forecast
10.2.3 Mexico Drug Reprofiling Market Forecast
10.2.4 Brazil Drug Reprofiling Market Forecast
10.3 APAC Drug Reprofiling Forecast by Region (2023-2028)
10.3.1 China Drug Reprofiling Market Forecast
10.3.2 Japan Drug Reprofiling Market Forecast
10.3.3 Korea Drug Reprofiling Market Forecast
10.3.4 Southeast Asia Drug Reprofiling Market Forecast
10.3.5 India Drug Reprofiling Market Forecast
10.3.6 Australia Drug Reprofiling Market Forecast
10.4 Europe Drug Reprofiling Forecast by Country (2023-2028)
10.4.1 Germany Drug Reprofiling Market Forecast
10.4.2 France Drug Reprofiling Market Forecast
10.4.3 UK Drug Reprofiling Market Forecast
10.4.4 Italy Drug Reprofiling Market Forecast
10.4.5 Russia Drug Reprofiling Market Forecast
10.5 Middle East & Africa Drug Reprofiling Forecast by Region (2023-2028)
10.5.1 Egypt Drug Reprofiling Market Forecast
10.5.2 South Africa Drug Reprofiling Market Forecast
10.5.3 Israel Drug Reprofiling Market Forecast
10.5.4 Turkey Drug Reprofiling Market Forecast
10.5.5 GCC Countries Drug Reprofiling Market Forecast
10.6 Global Drug Reprofiling Forecast by Type (2023-2028)
10.7 Global Drug Reprofiling Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Drug Reprofiling Product Offered
11.1.3 Novartis AG Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Information
11.2.2 Abbott Healthcare Drug Reprofiling Product Offered
11.2.3 Abbott Healthcare Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Healthcare Main Business Overview
11.2.5 Abbott Healthcare Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Drug Reprofiling Product Offered
11.3.3 Pfizer Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Drug Reprofiling Product Offered
11.4.3 Johnson & Johnson Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Hoffmann-La Roche
11.5.1 Hoffmann-La Roche Company Information
11.5.2 Hoffmann-La Roche Drug Reprofiling Product Offered
11.5.3 Hoffmann-La Roche Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Hoffmann-La Roche Main Business Overview
11.5.5 Hoffmann-La Roche Latest Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Drug Reprofiling Product Offered
11.6.3 Sandoz Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Sandoz Main Business Overview
11.6.5 Sandoz Latest Developments
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Information
11.7.2 Mylan Inc. Drug Reprofiling Product Offered
11.7.3 Mylan Inc. Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mylan Inc. Main Business Overview
11.7.5 Mylan Inc. Latest Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Information
11.8.2 Teva Pharmaceuticals Drug Reprofiling Product Offered
11.8.3 Teva Pharmaceuticals Drug Reprofiling Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Teva Pharmaceuticals Main Business Overview
11.8.5 Teva Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Drug Reprofiling Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Orally
Table 3. Major Players of Intravenously
Table 4. Drug Reprofiling Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drug Reprofiling Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drug Reprofiling Market Size Market Share by Type (2017-2022)
Table 7. Drug Reprofiling Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drug Reprofiling Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drug Reprofiling Market Size Market Share by Application (2017-2022)
Table 10. Global Drug Reprofiling Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drug Reprofiling Revenue Market Share by Player (2020-2022)
Table 12. Drug Reprofiling Key Players Head office and Products Offered
Table 13. Drug Reprofiling Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Reprofiling Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drug Reprofiling Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drug Reprofiling Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drug Reprofiling Market Size Market Share by Country (2017-2022)
Table 20. Americas Drug Reprofiling Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drug Reprofiling Market Size Market Share by Type (2017-2022)
Table 22. Americas Drug Reprofiling Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drug Reprofiling Market Size Market Share by Application (2017-2022)
Table 24. APAC Drug Reprofiling Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drug Reprofiling Market Size Market Share by Region (2017-2022)
Table 26. APAC Drug Reprofiling Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drug Reprofiling Market Size Market Share by Type (2017-2022)
Table 28. APAC Drug Reprofiling Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drug Reprofiling Market Size Market Share by Application (2017-2022)
Table 30. Europe Drug Reprofiling Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drug Reprofiling Market Size Market Share by Country (2017-2022)
Table 32. Europe Drug Reprofiling Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drug Reprofiling Market Size Market Share by Type (2017-2022)
Table 34. Europe Drug Reprofiling Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drug Reprofiling Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drug Reprofiling Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drug Reprofiling Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drug Reprofiling Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drug Reprofiling Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drug Reprofiling Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drug Reprofiling Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drug Reprofiling
Table 43. Key Market Challenges & Risks of Drug Reprofiling
Table 44. Key Industry Trends of Drug Reprofiling
Table 45. Global Drug Reprofiling Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drug Reprofiling Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drug Reprofiling Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drug Reprofiling Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drug Reprofiling Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drug Reprofiling Market Size Market Share Forecast by Application (2023-2028)
Table 51. Novartis AG Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 52. Novartis AG Drug Reprofiling Product Offered
Table 53. Novartis AG Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Novartis AG Main Business
Table 55. Novartis AG Latest Developments
Table 56. Abbott Healthcare Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 57. Abbott Healthcare Drug Reprofiling Product Offered
Table 58. Abbott Healthcare Main Business
Table 59. Abbott Healthcare Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Abbott Healthcare Latest Developments
Table 61. Pfizer Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 62. Pfizer Drug Reprofiling Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 67. Johnson & Johnson Drug Reprofiling Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Johnson & Johnson Latest Developments
Table 71. Hoffmann-La Roche Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 72. Hoffmann-La Roche Drug Reprofiling Product Offered
Table 73. Hoffmann-La Roche Main Business
Table 74. Hoffmann-La Roche Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Hoffmann-La Roche Latest Developments
Table 76. Sandoz Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 77. Sandoz Drug Reprofiling Product Offered
Table 78. Sandoz Main Business
Table 79. Sandoz Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Sandoz Latest Developments
Table 81. Mylan Inc. Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 82. Mylan Inc. Drug Reprofiling Product Offered
Table 83. Mylan Inc. Main Business
Table 84. Mylan Inc. Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Mylan Inc. Latest Developments
Table 86. Teva Pharmaceuticals Details, Company Type, Drug Reprofiling Area Served and Its Competitors
Table 87. Teva Pharmaceuticals Drug Reprofiling Product Offered
Table 88. Teva Pharmaceuticals Main Business
Table 89. Teva Pharmaceuticals Drug Reprofiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Teva Pharmaceuticals Latest Developments
List of Figures
Figure 1. Drug Reprofiling Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Reprofiling Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug Reprofiling Market Size Market Share by Type in 2021
Figure 7. Drug Reprofiling in Central Nervous Disorders
Figure 8. Global Drug Reprofiling Market: Central Nervous Disorders (2017-2022) & ($ Millions)
Figure 9. Drug Reprofiling in Cardiovascular Disorders
Figure 10. Global Drug Reprofiling Market: Cardiovascular Disorders (2017-2022) & ($ Millions)
Figure 11. Drug Reprofiling in Oncology
Figure 12. Global Drug Reprofiling Market: Oncology (2017-2022) & ($ Millions)
Figure 13. Drug Reprofiling in others
Figure 14. Global Drug Reprofiling Market: others (2017-2022) & ($ Millions)
Figure 15. Global Drug Reprofiling Market Size Market Share by Application in 2021
Figure 16. Global Drug Reprofiling Revenue Market Share by Player in 2021
Figure 17. Global Drug Reprofiling Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Drug Reprofiling Market Size 2017-2022 ($ Millions)
Figure 19. APAC Drug Reprofiling Market Size 2017-2022 ($ Millions)
Figure 20. Europe Drug Reprofiling Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Drug Reprofiling Market Size 2017-2022 ($ Millions)
Figure 22. Americas Drug Reprofiling Value Market Share by Country in 2021
Figure 23. Americas Drug Reprofiling Consumption Market Share by Type in 2021
Figure 24. Americas Drug Reprofiling Market Size Market Share by Application in 2021
Figure 25. United States Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Drug Reprofiling Market Size Market Share by Region in 2021
Figure 30. APAC Drug Reprofiling Market Size Market Share by Application in 2021
Figure 31. China Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Drug Reprofiling Market Size Market Share by Country in 2021
Figure 38. Europe Drug Reprofiling Market Size Market Share by Type in 2021
Figure 39. Europe Drug Reprofiling Market Size Market Share by Application in 2021
Figure 40. Germany Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Drug Reprofiling Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Drug Reprofiling Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Drug Reprofiling Market Size Market Share by Application in 2021
Figure 48. Egypt Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Drug Reprofiling Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 54. APAC Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 55. Europe Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 57. United States Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 58. Canada Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 61. China Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 62. Japan Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 63. Korea Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 65. India Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 66. Australia Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 67. Germany Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 68. France Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 69. UK Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 70. Italy Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 71. Russia Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 72. Spain Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 75. Israel Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Drug Reprofiling Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Drug Reprofiling Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
